For tirzepatide, compounded options exist as well
Understanding the proper dosing schedule is essential for anyone considering this promising triple-receptor medication
Biomarker-driven personalization Matching the right drug to the right patient One of the most exciting developments is the use of biomarkers, measurable biological indicators, to predict how a patient will respond to therapy
Image Credit: rasamma / Shutterstock A recent study published in the journal Pharmacological Research reviewed evidence on the effects of glucagon-like peptide 1 (GLP-1) receptor agonists (RAs) on skeletal muscle (SM) mass, quality, and function
Ahrens KA, Palmsten K, Lipkind HS, Ackerman-Banks CM
This inhibition was evidenced by Oil Red O and AdipoRed staining, and by the downregulation of key adipogenic markers, including peroxisome proliferator-activated receptor gamma ( PPAR ), lipoprotein lipase ( LPL ), fatty acid-binding protein 4 ( FABP4 ), and CCAAT/enhancer-binding protein alpha ( C/EBP ) [12, 13, 22, 23]